Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial.
Bos EM, Binda E, Verploegh ISC, Wembacher E, Hoefnagel D, Balvers RK, Korporaal AL, Conidi A, Warnert EAH, Trivieri N, Visioli A, Zaccarini P, Caiola L, van Wijck R, van der Spek P, Huylebroeck D, Leenstra S, Lamfers MLM, Ram Z, Westphal M, Noske D, Legnani F, DiMeco F, Vescovi AL, Dirven CMF.
Bos EM, et al. Among authors: balvers rk.
Mol Cancer. 2023 Aug 10;22(1):129. doi: 10.1186/s12943-023-01835-6.
Mol Cancer. 2023.
PMID: 37563568
Free PMC article.
Clinical Trial.